SFRP5 and obesity disorder: In that review, a study published in 2020 by Zhou et al. is addressed [199], demonstrating decreased circulating levels of SFRP5 in patients with obesity, and that high levels of SFRP5 in the tumor tissue were associated with better outcomes [199].